A substantial number are expressed in post-mortem ALS & ALS/FTD tissue with TDP-43 loss, underlining their potential involvement in pathogenic mechanisms and/or utility as biomarkers of TDP-43 pathology. This evidence concerns the gene TARDBP and amyotrophic lateral sclerosis.